von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure.
about
Type 2B von Willebrand disease with or without large multimers: A distinction of the two sides of the disorder is long overdueThe molecular basis of von Willebrand disease.Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor.von Willebrand factor, Jedi knight of the bloodstreamThe molecular biology of von Willebrand disease.Multiple substitutions in the von Willebrand factor gene that mimic the pseudogene sequence.Conformational changes in the A1 domain of von Willebrand factor modulating the interaction with platelet glycoprotein Ibalpha.Pathogenesis, clinical picture and treatment of von Willebrand's disease.Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. Charged-to-alanine scanning mutagenesis of the A1 domain of human von Willebrand factor.von Willebrand disease type 1 mutation p.Arg1379Cys and the variant p.Ala1377Val synergistically determine a 2M phenotype in four Italian patients.Appendix II: A revised classification of Von Willebrand disease*: For The Subcommittee on Von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor.
P2860
Q33442910-D1EF96B3-A8E2-4992-95E5-66D564FFB7D3Q33651554-74E5F358-5245-487D-A219-F5951FBC9248Q34022444-291F3E9D-E9A8-44C3-BDCC-DF564445F533Q34106824-CEE94131-5DAA-425A-BF1E-82BA3FBE7CE1Q34421530-3D03F7B7-5D75-4769-8AD0-597A1047BCFCQ35100545-32692137-27B8-4C4D-9B74-D51C240180CEQ38359108-2EBDA337-BA0A-454E-88EF-46A29C20A71EQ40999861-DBF9D360-28B6-47DF-BA1E-C0EE372052B0Q41336486-F2B7AD86-9219-440E-87A5-3B6CAF294C36Q45861284-E665A7E7-AB96-4277-A5AD-84F8A62B1C6FQ45886373-8C9F64D3-0265-4B37-A19A-26B91B27203AQ48152338-EE34A502-3E7A-437A-A765-4CDA74EDDBFF
P2860
von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure.
description
1993 nî lūn-bûn
@nan
1993 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
von Willebrand factor mutation ...... h normal multimeric structure.
@ast
von Willebrand factor mutation ...... h normal multimeric structure.
@en
type
label
von Willebrand factor mutation ...... h normal multimeric structure.
@ast
von Willebrand factor mutation ...... h normal multimeric structure.
@en
prefLabel
von Willebrand factor mutation ...... h normal multimeric structure.
@ast
von Willebrand factor mutation ...... h normal multimeric structure.
@en
P2093
P2860
P356
P1476
von Willebrand factor mutation ...... h normal multimeric structure.
@en
P2093
P2860
P304
P356
10.1172/JCI116443
P407
P577
1993-05-01T00:00:00Z